Physician profile
Angela Pham
NPI 1437344603
$13,569.69
in general payments reported to CMS, 2019-2025
20 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,647 · 2020: $77.94 · 2023: $187 · 2024: $11K · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,730 · Travel and Lodging: $1,424 · Food and Beverage: $532 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,730.00 |
| Travel and Lodging | $1,424.44 |
| Food and Beverage | $532.44 |
| Education | $158.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $11,565.34 | 2019-2024 | Tremfya |
| Abbvie INC. | $706.81 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $261.19 | 2019-2020 | |
| Amgen INC. | $222.49 | 2019-2025 | Evenity |
| Glaxosmithkline, LLC. | $173.47 | 2024-2025 | Benlysta, Nucala |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $91.00 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $83.99 | 2025 | Acthar |
| Celgene Corporation | $55.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.32 | 2019 | |
| Mallinckrodt Enterprises LLC | $41.28 | 2019 | |
| Genentech USA, INC. | $39.36 | 2019 | |
| Genzyme Corporation | $26.94 | 2024 | |
| Avanir Pharmaceuticals, INC. | $26.39 | 2019 | |
| Medexus Pharma, INC. | $23.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $19.25 | 2024 | |
| Amarin Pharma, INC. | $18.53 | 2019 | |
| Shire North American Group INC | $18.23 | 2019 | |
| Pfizer INC. | $16.80 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.